Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Aging (Upcoming)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • Gut-Brain Axis (Jul 2021)
    • Tumor Microenvironment (Mar 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI105906

Erythrocytes in human transplantation: effects of pretreatment with ABO group-specific antigens

F. T. Rapaport, J. Dausset, L. Legrand, A. Barge, H. S. Lawrence, and J. M. Converse

Department of Surgery and Institute of Reconstructive Plastic Surgery, New York University Medical Center, New York 10016

Institute de Recherches sur les Maladies du Sang, Hôpital Saint-Louis, University of Paris, France

Find articles by Rapaport, F. in: JCI | PubMed | Google Scholar

Department of Surgery and Institute of Reconstructive Plastic Surgery, New York University Medical Center, New York 10016

Institute de Recherches sur les Maladies du Sang, Hôpital Saint-Louis, University of Paris, France

Find articles by Dausset, J. in: JCI | PubMed | Google Scholar

Department of Surgery and Institute of Reconstructive Plastic Surgery, New York University Medical Center, New York 10016

Institute de Recherches sur les Maladies du Sang, Hôpital Saint-Louis, University of Paris, France

Find articles by Legrand, L. in: JCI | PubMed | Google Scholar

Department of Surgery and Institute of Reconstructive Plastic Surgery, New York University Medical Center, New York 10016

Institute de Recherches sur les Maladies du Sang, Hôpital Saint-Louis, University of Paris, France

Find articles by Barge, A. in: JCI | PubMed | Google Scholar

Department of Surgery and Institute of Reconstructive Plastic Surgery, New York University Medical Center, New York 10016

Institute de Recherches sur les Maladies du Sang, Hôpital Saint-Louis, University of Paris, France

Find articles by Lawrence, H. in: JCI | PubMed | Google Scholar

Department of Surgery and Institute of Reconstructive Plastic Surgery, New York University Medical Center, New York 10016

Institute de Recherches sur les Maladies du Sang, Hôpital Saint-Louis, University of Paris, France

Find articles by Converse, J. in: JCI | PubMed | Google Scholar

Published October 1, 1968 - More info

Published in Volume 47, Issue 10 on October 1, 1968
J Clin Invest. 1968;47(10):2206–2216. https://doi.org/10.1172/JCI105906.
© 1968 The American Society for Clinical Investigation
Published October 1, 1968 - Version history
View PDF
Abstract

Erythrocyte group antigens A and B can act as potent and group-specific transplantation antigens in man. ABO group-incompatible recipients pretreated with such antigens have rejected skin allografts obtained from donors incompatible for the same antigens in an accelerated (4-5 days) or white graft manner. Skin grafts applied to the same recipients from ABO-compatible donors were accorded first-set survival times. Intact erythrocyte suspensions and antigens isolated from hog (A substance) and horse (B substance) stomachs, were equally capable of inducing this type of allograft sensitivity. The latter observation broadens the spectrum of heterologous antigens capable of inducing allograft sensitivity in the mammalian host and provides a readily available, heat-stable, and water-soluble source of antigens for further studies of allograft rejection mechanisms in man.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 2206
page 2206
icon of scanned page 2207
page 2207
icon of scanned page 2208
page 2208
icon of scanned page 2209
page 2209
icon of scanned page 2210
page 2210
icon of scanned page 2211
page 2211
icon of scanned page 2212
page 2212
icon of scanned page 2213
page 2213
icon of scanned page 2214
page 2214
icon of scanned page 2215
page 2215
icon of scanned page 2216
page 2216
Version history
  • Version 1 (October 1, 1968): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2022 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts